Retatrutide 10mg (LY3437943) is a synthetic triple receptor agonist peptide designed to interact with GLP-1, GIP, and glucagon receptors in controlled laboratory and clinical research settings. It has gained attention as a next-generation investigational compound studied for its multi-pathway receptor activity and metabolic signaling mechanisms.

Explore research literature via PubMed database for Retatrutide studies

Buy Retatrutide 10mg – Dragon Pharma – Triple Agonist Peptide | Nexo Vira Lab

 Product Specifications

Specification	Details
Compound Name	Retatrutide (LY3437943)
Peptide Type	Triple receptor agonist
Quantity	10 mg per vial
Target Receptors	GLP-1, GIP, Glucagon
Form	Lyophilized powder
Manufacturer	Dragon Pharma
Appearance	White to off-white powder
Storage	Cool, dry, protected from light
Use	Research purposes only

 Scientific Background

In research environments, Retatrutide 10mg has been investigated for:

• Multi-receptor interaction across GLP-1, GIP, and glucagon pathways
• Extended receptor activation linked to peptide stability
• Experimental modeling of metabolic signaling pathways
• Combined incretin and glucagon receptor activity

Additional trusted resources:

• National Institutes of Health
• Food and Drug Administration

 Quality & Purity Assurance

• High-purity compounds verified through analytical testing
• Batch-level consistency and traceability
• Controlled manufacturing and storage conditions
• Secure packaging to maintain peptide stability

 Why Choose Nexo Vira Lab

✔ Trusted supplier of research-grade peptide compounds
✔ Emphasis on quality, transparency, and reliability
✔ Secure checkout and discreet delivery
✔ Consistent sourcing from reputable manufacturers
✔ Competitive pricing for single and bulk orders

Storage & Handling

• Store in a cool, controlled environment
• Protect from light, heat, and moisture
• Avoid repeated freeze–thaw cycles
• Follow standard laboratory handling procedures

 Frequently Asked Questions

What makes Retatrutide different from other peptides?
Retatrutide is a triple agonist, meaning it interacts with three receptor pathways instead of one or two, making it valuable for multi-pathway research.

What is the origin of Retatrutide?
It is an investigational peptide developed for metabolic research and currently being studied in advanced clinical trials.